Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. - Wikidata - wikimedia - TriplyDB

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

http://www.wikidata.org/entity/Q37737474

about

Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis

P2860

Q58701706-22F9B5B9-5CF9-4F26-B6BB-1FD0AF6C403A

P2860

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

http://www.wikidata.org/entity/Q37737474

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@en

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@nl

type

label

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@en

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@nl

prefLabel

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@en

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@nl

P1433

Q37737474-D189D41B-3787-494B-84D1-F4D473972F81

P1476

Q37737474-5784AF6A-4A62-4CFC-A6BF-05166BDF8B2F

P2093

Q37737474-3D43D7BE-67BC-4371-BC16-7F7A6FEA01CA

Q37737474-A8ECB91F-8A30-4630-BF33-822FF09ED774

Q37737474-BF6C1D96-823B-4D04-BCD0-75470B9B0DDB

Q37737474-E65C56C9-E259-44D2-9D21-95D5C385D467

Q37737474-F5E6CD3C-014E-4884-B76F-8E39AC37CB84

P2860

Q37737474-0544080C-130E-4AE1-AD0E-AEA787E215A5

Q37737474-0948A43D-1706-45B6-9216-6D1B70B8B704

Q37737474-146BE30B-F554-4657-BABC-21B96928D1E3

Q37737474-1A743AD1-2BCD-40B3-AA92-0CC87A9F3FA9

Q37737474-22865E55-A70A-412F-BD35-613D025FDD74

Q37737474-284E16F3-98F8-4360-94C3-894A39CF70D8

Q37737474-2ED8239E-AD0B-4E4D-807A-2300EE70C9DF

Q37737474-34B31B12-B977-4C71-92BD-9F36AEB608EA

Q37737474-3884A378-0394-4DD9-BD8D-9351673FD94E

Q37737474-3F5E4433-6909-47D9-92B5-8910AA23B21C

P2888

Q37737474-4B166151-232A-4BCB-A688-61C4F7E185D8

P304

Q37737474-06BBB4D4-953B-4CFF-BE19-E96ACA1868A1

P31

Q37737474-9677BBF5-BE7B-401A-9854-4720DB0FDB28

P356

Q37737474-BE666345-2A9D-4750-8A5E-BE208B4C8FFE

P433

Q37737474-7BA10B5D-338D-42D0-A9E1-3AF4BC05C353

P478

Q37737474-383D7B2F-DAC7-4A49-B162-A45B00B8958E

P50

Q37737474-D50C6384-9B40-4B37-89EA-C1A2E88A92D8

P577

Q37737474-98BE69AA-CB71-4A67-83CA-2596B1253D04

P698

Q37737474-5060C1C1-8CA1-4305-9A34-D1A6C6330D37

P921

Q37737474-3191D17E-7FE8-4D7D-9715-3661C9389DC1

Q37737474-561D9DC6-9E9A-4915-995C-E39B489BCFC9

P932

Q37737474-D054A2F9-8368-4F06-8F8F-D847AECB3AB7

P356

S13300-017-0245-8

P1433

Diabetes Therapy

P1476

Comparative Effectiveness of A ...... iew and Network Meta-Analysis.

@en

P2093

Eugene Benson

http://www.w3.org/2001/XMLSchema#string

Jorge Puelles

http://www.w3.org/2001/XMLSchema#string

Keith Tolley

http://www.w3.org/2001/XMLSchema#string

Ross Selby

http://www.w3.org/2001/XMLSchema#string

Stephen Kay

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Standards of medical care in diabetes--2006

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data.

Comparative effectiveness of dipeptidylpeptidase-4 inhibitors in type 2 diabetes: a systematic review and mixed treatment comparison

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis.

Triple therapy combinations for the treatment of type 2 diabetes - A network meta-analysis.

Triple therapy in type 2 diabetes; a systematic review and network meta-analysis.

P2888

s13300-017-0245-8

P304

251-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-017-0245-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Amanda Strickson

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275958

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5380505

http://www.w3.org/2001/XMLSchema#string